EYE National Vision Holdings, Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com. It also offers health maintenance organization and optometric services. In addition, the company sells prescription and non-prescription eyewear, contact lenses and related accessories to retail customers. The company serves a diverse customer base, including price-driven consumers, style leaders, wellness shoppers with vision benefits, managed care customers, outside prescription customers, and progressive lens wearers. The company was formerly known as National Vision, Inc. and changed its name to National Vision Holdings, Inc. in March 2014. The company was founded in 1990 and is headquartered in Duluth, Georgia.…
Industry Peers
Specialty RetailKey Statistics
About National Vision Holdings (NASDAQ: EYE)
›
National Vision Holdings (NASDAQ: EYE) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Retail industry, part of the Consumer Cyclical sector, and reports about 13,138 employees.
The shares were at 17.01 USD on 19 November 2026, down 27.5% over 52 weeks. Its 52-week range is 14.75 USD to 30.02 USD: the price is 43.3% below the high and 15.3% above the low.
At a market capitalisation of 1.33B USD, it trades at 20.7 times trailing earnings and 14.6 times forward earnings. The median trailing P/E of its 20 largest Specialty Retail peers is 16.6, a premium of 25% for EYE.
National Vision Holdings reports return on equity of 3.4%, an operating margin of 5.3% and revenue up 4.8% year over year.
Its debt exceeds its cash by 627.58M USD, a debt-to-equity ratio of 0.80. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 27.00 USD is 58.7% above the current price. The next earnings report is expected on 3 March 2027.